Walleye Trading
WX

Walleye Trading’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Walleye Trading’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,100
Closed -$48K – 6135
2015
Q3 		$48K Sell
1,100
-300
-21% -$12.7K ﹤0.01% 3541
2015
Q2 		$59K Buy
+1,400
New +$59K ﹤0.01% 3398

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Walleye Trading's WX Position: Q3 2015 in Review

Walleye Trading sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 462 shares — an estimated $19.5K sold.

Walleye Trading first reported a position in WX in Q2 2015 and held it in 1 quarter. The position peaked at $20K in Q2 2015. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

  • Walleye Trading reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
  • Walleye Trading sold 462 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $19.5K.
  • Walleye Trading first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 1 quarter.
  • Walleye Trading's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $20K in Q2 2015.
  • 151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Walleye Trading's 13F filing for Q3 2015, filed 16 Nov 2015.